Scanogen is a molecular diagnostic company developing systems to read the biomolecular information of body fluids with the goal of improving health care. The Company has developed Single MOLecule Tethering (SMOLT), a proprietary technology for rapid and ultra-sensitive detection of biomolecules. The Company is using this technology to develop a simple-to-use and sample-to-answer diagnostic platform. Scanogen has received NIH grants totaling $9.5 million to develop its diagnostic assays and it is currently focused on two areas: Point-of-care diagnosis and bloodstream infection detection.

Biotechnology

Health Care

Life Sciences

Scanogen Inc.

Scanogen Inc.'s headquarters in Milford Mill, MD, United States

This department conducts research and innovation to develop new products and technologies.

Research and Development

This department is responsible for managing laboratory activities and ensuring the efficient operation of testing and research functions.

People (2)

Jobs (0)

Other teams

Laboratory Operations